---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-061438"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:23:16.914250+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools sells SomaLogic to Illumina for up to $425M; expects $550M cash at close

## Summary
- Upfront cash payment of $350M at closing plus up to $75M in near-term earnout milestones for total up to $425M.
- Retains 2% royalty on Illumina Protein Prep NGS kit sales for 10 years and co-exclusive Single SOMAmer rights.
- Transaction simplifies operating structure; expects to achieve adjusted EBITDA break-even post-close.
- Pro forma cash & equivalents of at least $550M at close to fund inorganic growth strategy.
- Expected close in H1 2026, subject to HSR clearance and other customary conditions.

## SEC filing metadata
- accession: 0001104659-25-061438
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000110465925061438/0001104659-25-061438-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000110465925061438/tm2518613d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-061438
- JSON: https://secwatch.observer/filing/0001104659-25-061438.json
- Plain text: https://secwatch.observer/filing/0001104659-25-061438.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.